Friday, 27 May, 2022
E-paper

Incepta launches Pfizer’s anti-Covid pill

  • Staff Correspondent
  • 20 January, 2022 12:00 AM
  • Print news
Incepta launches Pfizer’s anti-Covid pill

Popular News

Incepta has announced the launching of Pfizer's oral antiviral medication – Paxlovid – for the treatment of Covid-19.

Incepta Pharmaceut- icals Limited will market the drug under the brand name of Jupitavir, said a press release.

The Directorate General of Drug Administration (DGDA) granted emergency use authorisation for the drug to treat mild-to-moderate Covid-19 patients including adults and children aged 12 years and above.

Earlier on December 22, the US Food and Drug Administration (US FDA) granted emergency use authorisation to the drug as the first approved oral therapy for Covid-19 treatment.